ArticleJournal of diabetes and metabolic disorders2026
Association of conventional and non-conventional lipid profile with cognitive impairment among type 2 diabetic patients.
Article in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the connection between atherogenic index of plasma, non-HDL-C, as well as conventional lipid profiles in relation to cognition dysfunction among the diabetic participants aged over 60 years. Methods: The data of this cross-sectional research study came from the Bushehr Elderly Health (BEH) Program (Phase II) carried on the participants aged 60 and above. The functional status of the participants was assessed using the Functional Assessment Staging tool (FAST) and Category Fluency Test (CFT). After the measurement of lipid parameters, we used multiple logistic regression to analyze their relationship with cognitive impairment (CI) among the participants. Results: There were 836 participants in this cross-sectional study. Of them, 339 had cognitive decline. The average age of the subjects was 68.6 ± 5.7 years. There was no relationship between lipid parameters and cognition dysfunction with the exception of HDL-C. A higher amount of HDL-C had a protective role. While older age (OR = 1.05, 95% CI = 1.01-1.08, Conclusion: Among conventional lipid profiles, only the HDL-C levels were related to cognitive dysfunction and no relationship was observed between cognitive impairment and non-conventional lipids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.